Mesothelioma diagnosis is often a case of mistaken identity. Pathologists can have a hard time telling it apart from other cancers, particularly adenocarcinoma—a type of cancer that affects the glands. One new marker—podoplanin—could help pathologists more accurately distinguish mesothelioma from other types of cancer, according to a study published online February 9 in the journal, Diagnostic Cytopathology. Mesothelioma can be challenging to diagnose for pathologists who see just one case of this rare cancer every few years. Even with the most sensitive tests available, mesothelioma can be mistaken for other cancers, particularly adenocarcinoma. “The treatment is different. So it’s important to diagnose mesothelioma to get the right treatment,” explains Claire W. Michael, MD, Professor of Pathology and Director of Cytopathology at … Continue reading New Mesothelioma Marker May Help In Diagnosis »